Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib.
The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib. Curr Hematol Malig Rep. 2020 12; 15(6):409-418.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Benzamides
Biomarkers
Bridged-Ring Compounds
Clinical Trials as Topic
Disease Management
Disease Progression
Disease Susceptibility
Humans
Janus Kinase Inhibitors
Molecular Targeted Therapy
Myeloproliferative Disorders
Pyrimidines
Pyrrolidines
Sulfonamides
Treatment Outcome
authors with profiles
Olatoyosi Odenike
Anand Patel